| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 128,363 | - |
| Depreciation and amortization | 135,591 | 87,080 |
| Non-cash rental and related revenues | 820 | -6,331 |
| Non-cash interest income | -7 | -7 |
| Non-cash interest expense | 5,608 | 3,455 |
| Stock-based compensation expense | 8,290 | 5,415 |
| Loss on extinguishment of debt | -1,154 | - |
| Recovery of loan losses | -640 | -400 |
| Net (gain) loss on sales of real estate | 5,544 | 9,974 |
| Impairment of real estate | 6,674 | 4,103 |
| (income) loss from unconsolidated joint ventures | 2,276 | 1,050 |
| Distributions of earnings from unconsolidated joint ventures | 5,917 | 4,022 |
| Net income | - | 105,846 |
| Other non-cash items | -17,190 | -17,190 |
| Accounts receivable, prepaid expenses and other assets, net | 9,129 | 6,867 |
| Accounts payable and accrued liabilities | 3,541 | -6,894 |
| Net cash provided by operating activities | 261,186 | 161,222 |
| Acquisition of real estate and lease intangibles | 301,563 | 61,137 |
| Origination and fundings of loans receivable | 5,710 | 3,110 |
| Origination and fundings of preferred equity investments | 9 | 9 |
| Additions to real estate | 24,183 | 13,569 |
| Escrow deposits for potential investments | 500 | - |
| Repayments of loans receivable | 15,442 | 7,048 |
| Repayments of preferred equity investments | -1,977 | -1,369 |
| Investment in unconsolidated joint ventures | 1,241 | 1,241 |
| Net proceeds from the sales of real estate | 43,087 | 3,573 |
| Proceeds from net investment hedges | 4,462 | 4,462 |
| Insurance proceeds | 1,267 | 1,038 |
| Distributions in excess of earnings from unconsolidated joint ventures | 5,557 | - |
| Net cash used in investing activities | -261,414 | -61,576 |
| Net borrowings from revolving credit facility | 174,805 | 55,144 |
| Principal payments on senior unsecured notes | 500,000 | - |
| Proceeds from term loans | 500,000 | - |
| Principal payments on secured debt | 1,562 | 1,038 |
| Payments of deferred financing costs | 4,405 | 80 |
| Payments related to extinguishment of debt | 2,884 | - |
| Contributions from noncontrolling interests | 2,040 | - |
| Issuance of common stock, net | 188,350 | 24,211 |
| Dividends paid on common stock | 214,692 | 142,754 |
| Net cash provided by (used in) financing activities | 141,652 | -64,517 |
| Net increase in cash, cash equivalents and restricted cash | 141,424 | 35,129 |
| Effect of exchange rate changes on cash | -245 | - |
| Cash and cash equivalents at beginning of period | 66,339 | - |
| Cash and cash equivalents at end of period | 207,518 | - |
Sabra Health Care REIT, Inc. (SBRA)
Sabra Health Care REIT, Inc. (SBRA)